Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  This percentage is calculated based upon 10,793,057 shares of the Issuers common stock outstanding as of December 31, 2024, in accordance with 20F filed on March 19, 2025. However, as more fully described in Item 4, the securities reported in rows 6, 8, and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8, and 9. (6) 407,061 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person:  (6) 407,061 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person:  (6) 407,061 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person:  (6) 407,061 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G



 
Rosalind Advisors, Inc.
 
Signature:Steven Salamon
Name/Title:President
Date:08/12/2025
 
SALAMON STEVEN A J
 
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:08/12/2025
 
Aharon Gil
 
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:08/12/2025
 
Rosalind Master Fund L.P.
 
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:08/12/2025

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

exh_a_joint_filing.htm